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Abstract
Nodal is aTGF-β familymember ligand that is critical for early embryonic patterning
in vertebrates. Nodal signaling functions through core TGF-β receptors to activate a
Smad transcription factor signaling cascade. However, unlike other TGF-β ligands,
Nodal signaling requires an additional co-receptor of theEGF-CFC family to activate
intracellular signaling. Nodal signaling is also subject to extensive negative regula-
tion by Lefty and other factors. Work in numerous model organisms, including
mouse, chicken, and zebrafish, established that Nodal signaling plays an essential
role during germ layer formation, anterior-posterior axis patterning, and left-right
axis determination. Incomplete or delayed loss ofNodal signaling results in defective
organogenesis and birth defects, including congenital heart defects, and clinical
studies have linked aberrant Nodal signaling in humans withmany common congen-
ital malformations, including congenital heart defects. Congenital heart defects
associated with disrupted Nodal signaling in mammals include those that arise due
to global defects in left-right patterning of the embryo, such as heterotaxy. Other
Nodal-associated heart defects appear to occur asmore subtle isolatedmalformations
of the great arteries and atrioventricular septum, which may not be related to overall
perturbations in laterality. A more detailed understanding of the Nodal signaling
pathway and its targets in the heart is required to more fully understand the etiology
of Nodal signaling pathway-associated congenital heart defects.
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The Nodal signaling pathway is critical for early embryonic patterning in all
vertebrates. Nodal is a secreted signaling molecule that belongs to the transforming
growth factor-β (TGF-β) family and functions primarily to activate downstream
signaling through a receptor-mediated response [1–3]. The Nodal pathway plays a
critical role in mesoderm specification and anterior-posterior patterning during
gastrulation and is also essential for establishing the left-right axis in the developing
embryo [4–7]. Changes in Nodal expression or dosage can disrupt left-right pat-
terning and result in a range of congenital defects that affect development of the
forebrain, the craniofacial skeleton, and several other organs, including the heart.
24.2 The Nodal Signaling Pathway
The Nodal signaling pathway shares many similarities with other TGF-β signaling
pathways in that it utilizes core Smad-dependent signaling components (Fig. 24.1).
Nodal is secreted extracellularly as a proprotein homodimer like other TGF-β
ligands [8]. Once cleaved into the mature ligand, the Nodal homodimer binds
tightly to a TGF-β receptor heterodimer consisting of both Type I and Type II
receptors [9]. Nodal ligand binding causes the constitutively active Type II receptor
serine/threonine kinases to associate with the inactive Type I receptor kinases and
leads to phosphorylation and the subsequent dissociation of R-Smad from the
TGF-β receptor [10]. Following formation of a trimeric complex composed of
two R-Smads and the common partner Smad, Smad4, the Smad oligomer
translocates to the nucleus where it regulates gene expression through direct and
indirect DNA binding (Fig. 24.1) [1, 11, 12].
The Nodal signaling pathway has important distinctions from other
TGF-β-mediated signaling pathways. Nodal can only activate TGF-β receptor
signaling in the presence of an EGF-CFC protein (Fig. 24.1). There are two
EGF-CFC proteins, Cripto and Cryptic, which function as co-receptors for Nodal
[13]. Cripto and Cryptic are extracellular proteins that contain an epidermal growth
factor-like motif and a novel cystine-rich domain named the CFC [13]. EGF-CFC
proteins function primarily by binding to the Type II TGF-β receptor through the
CFC domain and by binding to Nodal through the EGF domain [14].
In response to Nodal signaling, the Smad complex cooperates specifically with
FoxH1, a winged helix transcription factor, or Mixer, a member of the Mix subclass
of homeodomain proteins [15, 16]. These cofactors are critical for Nodal-dependent
downstream gene activation and act to stabilize Smad-DNA interactions, since
Smads have relatively weak DNA-binding affinity [17, 18]. FoxH1 and Mixer
recruit the Smad complex to promoter and enhancer elements and help to establish
temporal and spatial regulation of Nodal-dependent target genes.
In addition, the Nodal signaling pathway is subject to specific negative regula-
tion not found for other TGF-β family members. Proteins of the Lefty family,
specifically Lefty1 and Lefty2, inhibit Nodal-dependent activation of TGF-β
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Fig. 24.1 The Nodal signaling pathway. The Nodal ligand binds to a dimer of the TGF-β Type I
and Type II receptors. In association with an EGF-CFC co-receptor (Cripto or Cryptic), Nodal
activates the receptor complex causing the phosphorylation of either Smad2 or Smad3 followed by
oligomerization with the common partner Smad4. The Smad2/Smad3-Smad4 complex then
translocates to the nucleus where it binds to DNA with the transcriptional cofactor FoxH1 or
Mixer, leading to transcription of downstream target genes. The Nodal signaling pathway is
negatively regulated by proteins such as Lefty, which can bind to either EGF-CFC or the Nodal
dimer to prevent activation of the receptor complex, or TGIF1, which recruits histone deacetylases
to Smad2/Smad3 and represses transcriptional activation
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receptors by interacting directly with the Nodal ligand and preventing binding to
the TGF-β receptor heterodimer and by binding to the EGF-CFC Nodal
co-receptors Cripto and Cryptic and preventing their association with the TGF-β
receptor complex (Fig. 24.1) [19–21].
24.3 Requirement for Nodal in Development
Nodal signaling is critical for the patterning of the developing embryo [4, 22]. Loss-
of-function studies in vertebrate model organisms indicate that Nodal signaling is
first required during gastrulation. Germline loss of Nodal in mice results in severe
patterning and differentiation defects and embryonic lethality due to a failure to
induce the primitive streak from the ectoderm and to disrupted specification of
mesoderm and endoderm from the epiblast [5]. Additionally, loss of Nodal in mice
results in impaired anterior-posterior axis formation due to the lack of anterior
visceral endoderm formation [22]. The requirement of Nodal signaling for early
embryonic pattern formation was further highlighted by loss-of-function studies of
the EGF-CFC Nodal co-receptor Cripto. Inactivation of Tdgf1, the gene encoding
Cripto, in mice results in a phenocopy of early Nodal defects, including lethality
shortly after gastrulation. Tdgf1 mutants lack a primitive streak, fail to form
embryonic mesoderm, and exhibit anterior-posterior axis defects [6]. The one-
eyed pinhead (oep) mutation in zebrafish results in a complete loss of function of
the fish ortholog of the Nodal co-receptor Cripto [23]. These mutants exhibit a
phenocopy of the early Nodal defects seen in mice, including an absence of
mesoderm and anterior-posterior axis abnormalities [23]. Together, both animal
models establish that EGF-CFC proteins are required for Nodal signaling and
support an early requirement for the Nodal pathway in embryo morphogenesis.
Following gastrulation, Nodal signaling is indispensable for the establishment of
left-right asymmetry. Conditional deletion of Nodal in the lateral plate mesoderm in
mice circumvents the early requirement for Nodal signaling during gastrulation and
results in heterotaxy, a condition characterized by left-right ambiguity of thoracic
and abdominal visceral organs [24]. These mice exhibit transposition of the great
arteries of the heart, right-sided isomerism of the lungs, and right-sided stomach
[25]. Similarly, germline deletion of Cfc1, the gene encoding Cryptic, results in
left-right laterality defects with mutants exhibiting heterotaxy [26].
In addition to playing a role in the establishment of laterality following gastru-
lation, Nodal signaling is also required for midline patterning of the ventral
forebrain [27]. Zebrafish mutants for the Nodal ligands and for the ortholog of
Cripto result in holoprosencephaly, a condition where bifurcation of the ventral
forebrain fails to occur and results in fusion of the two brain hemispheres [28]. Sim-
ilarly, mice heterozygous for germline knockout alleles of both Nodal and Smad2
have cyclopia, a rare and severe form of holoprosencephaly [29], further supporting
the relationship between Nodal signaling and forebrain development. Mechanisti-
cally, this phenotype is thought to occur due to the patterning of Sonic Hedgehog
(Shh) expression in the forebrain by Nodal [30, 31].
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24.4 Congenital Heart Defects Associated with Perturbations
in Nodal Signaling
It is perhaps not surprising to find that the Nodal signaling pathway is associated
with pathogenesis in humans, given its critical role in patterning during embryonic
development. Nodal signaling was first linked to human congenital defects through
the identification of mutations associated with left-right laterality defects. These
include mutations in genes encoding Lefty family members, the EGF-CFC
co-receptor Cryptic, and the Type II TGF-β receptors [32–34]. In addition,
mutations in genes encoding transcriptional inhibitors of Smad2, such as TGIF1,
are associated with holoprosencephaly, a defect strongly associated with disrupted
Nodal signaling [30, 35]. Interestingly, these human pathologies are similar to the
defects observed in animal models with defective (but not incomplete) Nodal
signaling.
Congenital heart defects have also been linked to aberrant Nodal signaling
(Table 24.1) [36]. Loss-of-function mutations in genes encoding numerous Nodal
signaling components, including Nodal, Cripto, Cryptic, and FoxH1, have been
identified in patients with heart defects [37, 38]. The spectrum of heart defects in
these patients can be roughly grouped into two broadly defined classes: (1) those
that occur as a result of overall isomerism or heterotaxy and (2) those that occur as
isolated congenital heart defects. The isomerisms of the heart can be classified as
situs inversus totalis, a complete mirror image of the visceral organs of the body
including the heart, or situs inversus ambiguous, where the abdominal and visceral
organs are distributed abnormally and randomly in a condition more commonly
called heterotaxy [39]. Both of these conditions can be linked to aberrant Nodal
signaling [40]. Heterotaxy often results in complex congenital heart defects
[41, 42]. These defects include levo-transposition of the great arteries (l-TGA)
and atrial isomerism [36, 39]. The feature characteristics of l-TGA are improper
positioning of the aorta and the pulmonary artery such that the arteries are switched
in conjunction with the ventricles such that they still have the normal relationship
between the ventricles and the arteries [43].
Isolated congenital heart defects associated with Nodal mutations can result in
structural and functional abnormalities that appear to be independent of overall left-
right ambiguity. These isolated defects include dextro-transposition of the great
arteries (d-TGA), double outlet right ventricle (DORV), tetralogy of Fallot, and
isolated ventricular septal defects [37, 38]. Unlike l-TGA, which results in a proper
alignment of the arteries with respect to the ventricles, d-TGA results in a switching
of aorta and the pulmonary artery such that the pulmonary artery connects to the left
ventricle and the aorta emanates from the right ventricle [43]. DORV, as the name
implies, occurs when the aorta and the pulmonary artery connect to the right
ventricle. Tetralogy of Fallot is essentially a milder form of DORV in which the
aorta overrides the ventricular septum and empties blood from both ventricles
[44]. There is also pulmonary artery stenosis and a hypertrophic right ventricle
secondary to pulmonary artery blockage associated with tetralogy of Fallot
[44]. These defects appear to be independent of overall laterality, although the
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mechanistic basis for why these defects occur when Nodal signaling is disrupted is
unclear. Interestingly, Nodal expression occurs well prior to the patterning and final
alignment of the aorta and pulmonary artery [40]. Furthermore, the temporal
expression pattern of Nodal observed during development is tightly regulated
within a narrow developmental window due, at least in part, to the extensive
negative feedback by Lefty proteins and other factors. The diverse nature of
heterotaxy in humans suggests that some isolated congenital heart defects
associated with perturbed Nodal signaling may still be secondary to overall
laterality defects.
A role for Nodal signaling in isolated congenital heart defects is also supported
by studies in mice in which subtle perturbations of Nodal signaling result in less
severe defects (Table 24.1), suggesting that the Nodal ligand functions in a dosage-
dependent manner. For example, deletion of an intronic enhancer of Nodal resulted
in decreased expression of Nodal in the lateral plate mesoderm. These mouse
Table 24.1 Some of the congenital defects associated with altered Nodal signaling in mammals
Component Species CV defects Other defects References






















Mouse l-TGA, ASD Heterotaxy, r-isomerism of
the lung, hyposplenia
[26]
Cripto Human TOF, VSD, ASD HPE [37, 50,
51]




Smad2 Human Dextrocardia, d-TGA,
DORV, ASD
Heterotaxy, asplenia, HPE [37, 53]





R-isomerism of the lung,
axial skeleton abnormalities
[54]
FoxH1 Human VSD, TGA, TOF HPE [37, 55]
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embryos developed laterality defects that were less severe than the heterotaxy
observed in Nodal conditional knockouts where Nodal expression in lateral plate
mesoderm was completely abolished [25, 45].
Consistent with Nodal function in left-right patterning, Nodal-dependent target
genes are also critical for left-right patterning and heart development [21]. Pitx2 is
perhaps the best-described target gene of Nodal signaling and is expressed asym-
metrically on the left side after gastrulation [46]. Misexpression of Pitx2 on the
embryonic right side in mice results in heterotaxia with conditions such as aberrant
heart looping, cardiac isomerism, and visceral organ laterality defects [46]. In the
mouse, germline loss of function of Pitx2 results in left-right asymmetry defects in
specific organs, such as the lung [47]. Interestingly, Pitx2-null and isoform-specific
Pitx2c-null embryos undergo normal heart looping but have a subset of congenital
cardiovascular anomalies such as DORV and ventricular and atrial septal defects
[47, 48]. These observations suggest that Pitx2 functions in heart development after
left-right determination and that other Nodal-dependent target genes may be
required for cardiac laterality. Together, these observations suggest that other
unappreciated Nodal-dependent target genes are involved in the establishment of
left-right identity and cardiac development. A more detailed elucidation of this
fundamental pathway, including target genes in the cardiac mesoderm, is required
to more fully understand the role of Nodal signaling in heart development and in
congenital heart defects.
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